Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience
Abstract Extraordinary advances in medicine and public health have contributed to increasing life expectancy worldwide. However, health span—“healthy aging”—has paradoxically lagged to parallel this increase. Consequently, aging‐associated illnesses, such as Alzheimer's disease and aging frailt...
Main Authors: | Anthony A. Oliva, Lisa McClain‐Moss, Andrea Pena, Amy Drouillard, Joshua M. Hare |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Aging Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/agm2.12079 |
Similar Items
-
Meta‐inflammaging at the crossroad of geroscience
by: Guobing Chen, et al.
Published: (2019-09-01) -
Osteosarcopenia: A case of geroscience
by: Ben Kirk, et al.
Published: (2019-09-01) -
Geroscience infrastructure building in China
by: Xiang Liu, et al.
Published: (2019-09-01) -
Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19
by: Alan Landay, et al.
Published: (2021-07-01) -
Review on the mesenchymal stem cells and their potential application in regenerative medicine
by: M. Nassiri Asl, et al.
Published: (2018-02-01)